According to the research report, the global nutritionalsupplements market size is expected to touch USD 624.7 Billion by 2030, from USD 335.24 Billion in 2021, growing with a significant CAGR of 7.1% from 2022 to 2030.
The nutritional supplements report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global nutritional supplements in
conjunction with the geographical landscape of this vertical have also been
included in this report.
The report offers intricate dynamics about
different aspects of the global nutritional supplements market, which aids
companies operating in the market in making strategic development decisions.
The study also elaborates on significant changes that are highly anticipated to
configure growth of the global nutritional supplements during the forecast
period. It also includes a key indicator assessment that highlights growth
prospects of this market and estimates statistics related to growth of the
market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/1325
Report Highlights | Details |
Market Size | USD 624.7 Billion by 2030 |
Growth Rate | CAGR of 7.1% From 2022 to 2030 |
Largest Market | Asia Pacific |
Fastest Growing Market | Latin America |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Form, Product, Age Group, Distribution Channel, Region |
This study covers a detailed segmentation
of the global nutritional supplements market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global nutritional supplements market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- Abbott Nutrition
- Amway
- Nestle
- Glanbia Plc
- Herbalife International of America
- Archer Daniels Midland
- GlaxoSmithKline
- Nature’s Bounty Co.
- Arkopharma Laboratories Pharmaceutiques
- DuPont
- American Health, Inc.
- Pfizer, Inc.
- Stepan Company
Market Segmentation
- Powder
- Tablets
- Capsules
- Liquid
- Soft gels
- Others
By Product Type
- Sports Nutrition
- Dietary Supplements
- Fat Burner
- Functional Food
- Others
By Age Group
- Kids
- Adults
- Geriatric
By Distribution Channel
- Supermarkets/Hypermarkets
- Specialty Stores
- Pharmacies
- E-commerce
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global nutritional supplements report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global nutritional supplements market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Nutritional Supplements Market
5.1. COVID-19 Landscape: Nutritional Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Nutritional Supplements Market, By Form
8.1. Nutritional Supplements Market, by Form Type, 2021-2030
8.1.1. Powder
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Tablets
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Capsules
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Liquid
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Soft gels
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Nutritional Supplements Market, By Product
9.1. Nutritional Supplements Market, by Product, 2021-2030
9.1.1. Sports Nutrition
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Dietary Supplements
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Fat Burner
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Functional Food
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Nutritional Supplements Market, By Age Group
10.1. Nutritional Supplements Market, by Age Group, 2021-2030
10.1.1. Kids
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Adults
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Nutritional Supplements Market, By Distribution Channel
11.1. Nutritional Supplements Market, by Distribution Channel, 2021-2030
11.1.1. Supermarkets/Hypermarkets
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Specialty Stores
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Pharmacies
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. E-commerce
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Nutritional Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Form (2019-2030)
12.1.2. Market Revenue and Forecast, by Product (2019-2030)
12.1.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Form (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Form (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Form (2019-2030)
12.2.2. Market Revenue and Forecast, by Product (2019-2030)
12.2.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Form (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Form (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Form (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Form (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Form (2019-2030)
12.3.2. Market Revenue and Forecast, by Product (2019-2030)
12.3.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Form (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Form (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Form (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Form (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Form (2019-2030)
12.4.2. Market Revenue and Forecast, by Product (2019-2030)
12.4.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Form (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Form (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Form (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Form (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Form (2019-2030)
12.5.2. Market Revenue and Forecast, by Product (2019-2030)
12.5.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Form (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Form (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Age Group (2019-2030)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2030)
Chapter 13. Company Profiles
13.1. Abbott Nutrition
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Amway
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nestle
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Glanbia Plc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Herbalife International of America
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Archer Daniels Midland
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GlaxoSmithKline
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Nature’s Bounty Co.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Arkopharma Laboratories Pharmaceutiques
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. DuPont
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. American Health, Inc.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Pfizer, Inc.
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. Stepan Company
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments